medigraphic.com
SPANISH

Acta Médica del Centro

ISSN 1995-9494 (Electronic)
Revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro"
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 1

<< Back Next >>

Acta Med Cent 2012; 6 (1)

Epidemiological, clinical, endoscopic and histological characterization of gastric cancer

Morales MI, Hernández CMO, Rodríguez PA, Lara MM, Valdés LR, Reyes VJM
Full text How to cite this article

Language: Spanish
References: 20
Page:
PDF size: 50.70 Kb.


Key words:

stomach neoplasms/epidemiology.

ABSTRACT

Gastric cancer is a health problem worldwide. In order to characterize the disease, a descriptive prospective study was conducted at the Arnaldo Milian Castro and the Celestino Hernández Robau University Hospitals during 2009. It measured socio-demographic, clinical, endoscopic and histological variables. The most common risk factors in patients with gastric cancer were the male sex (64.3%), an age between 51 and 60 years (35.7%), insufficient consumption of fruits and vegetables (81.0%), blood group A (45.2%) and chronic gastritis (26.2%). The main symptom was epigastric pain (64.3%) and the predominant signs were hematemesis and melena, both in 16.7% of cases. The main endoscopic findings were the ulcerated type of gastric cancer and a location at the level of the body (56.1% and 29.3% respectively). The diffuse-type adenocarcinoma was the predominant histologic type (56.4%), and the early diagnosis of gastric cancer is the key to a successful treatment.


REFERENCES

  1. Maruyama K. Gastric cancer in Japan, treatment results of 219, 119 patients in nationwide registry in 29 years. Conferencia inaugural. São Paulo, Brasil: Séptimo Congreso Internacional de Cáncer Gástrico, mayo de 2007.

  2. Morales Chamorro R, Méndez Vidal MJ, Aranda Aguilar E. Cáncer de estómago. Medicine. 2005;9(25):1613-20.

  3. Parkin DM. Global cáncer statistics in the year 2000. Lancet Oncol. 2001;2(9):533- 43.

  4. Mortalidad por cáncer de estómago. En: Anuario Estadístico de Salud. La Habana: MINSAP; 2009.

  5. Parsonnet J, Peter G. Bacterial infection and MALT lymphoma. N Engl J Med. 2004;350(3):213-15.

  6. Larsson SC, Bergkvist L, Wolk A. Fruit and vegetable consumption and incidence of gastric cancer: A prospective study. Cancer Epidemiol Biomarkers Prev. 2006;15:1998-2001.

  7. Kim H, Lim Y. Fresh and pickled vegetable consumption and gastric cancer in Japanese and Korean populations: a meta-analysis of observational studies. Cancer Sci. 2010;101(2): 508-16.

  8. Rugge M. Gastritis OLGA-staging & gastric cancer risk: a twelve year clinicopathological follow-up study. Aliment Pharmacol Ther. 2010;122(2):208-16.

  9. González CA, Pera G, Agudo A, Bueno-de-Mesquita HB, Ceroti M, Boeing H, et al. Fruitand vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer. 2006;118:2559-66.

  10. 10.Lochhead P, El-Omar EM. Helicobacter pylori infection and gastric cancer. Cáncer Causes Control. Best Pract Res Clin Gastroenterol. 2007;21:281-97.

  11. 11.Rocco A, Nardone G. Diet H. Pylori infection and gastric cancer: evidence and controversies. World J Gastroenterol. 2007;13:2901-12.

  12. 12.Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterol. 2007;133:659-72.

  13. 13.Rhead JL, Letley DP, Mohammadi M. A new Helicobacter pylori vacuolating cytotoxin determinant the intermediate region is associated with gastric cancer. Gastroenterol. 2007; 133:926-37.

  14. 14.Chiba T, Marasawa H, Seno H. Mechanisms for gastric cáncer development by Helicobacter pylori infection. J Gastroenterol Hepatol 2008; aug;23(8 Pt 1):1175-81. Epub 2008 Jun 10.

  15. 15.Trepe CM, Kim N. El riesgo de cáncer de estómago en los pacientes de cáncer gástrico: la interacción entre la Helicobacter pylori infección e historia de la familia de cáncer gástrico para el riesgo de cáncer del estómago. J Clin Gastroenterol. 2010;44(2):34-9.

  16. 16.Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Megraud F, Xiao SD, et al. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state of the art critique. Am J Gastroenterol. 2005;100:2100-15.

  17. 17.Mera R, Fontham E, Bravo L, Piazuelo M, Camargo M, Correa P. Long term follow-up of patients treated for Helicobacter pylori infection. Gut. 2005;54:1536-40.

  18. 18.Liu XY, Liang H. Analysis of clinicopathological characteristics and prognosis of patients with gastric cáncer in different locations after radical resection. Zhonghua Wei Chang Wai Ke Za Zhi. 2010;13(3):181-84.

  19. 19.Axon A. Symptoms and diagnosis of gastric cancer at early curable stage. Best Pract Res Clin Gastroenterol. 2006; 20:697-708.

  20. Llorens Sabaté P. Diagnóstico endoscópico del cáncer gástrico. En: Cáncer Gástrico:capítulos escogidos. Santiago de Chile: Laboratorios Saval; 2001. p. 37-98.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med Cent. 2012;6